Hydrothermally treated product of compound having hydrotalcite-like crystal structure composition thereof, and use thereof
AssigneeKyowa Chemical Industry Co., Ltd.
InventorsShigeo Miyata, Hitoshi Anabuki
Life of this patent
Estimating the term…
Loading patent…
AssigneeKyowa Chemical Industry Co., Ltd.
InventorsShigeo Miyata, Hitoshi Anabuki
Estimating the term…
A hydrothermally treated product useful for treating an iron deficiency of a compound having a hydrotalcite-like crystal structure and represented by the following formula (I) (Fe.sup.2+,Mg.sup.2+).sub.x (Al.sup.3+,Fe.sup.3+).sub.2 (OH).sub.2x+6-nz (A.sup.n-).sub.z.mH.sub.2 O (I) wherein A.sup.n- represents an anion having a valence of n, Mg.sup.2+ is within the range of O.ltoreq.Mg.sup.2+ <x, Fe.sup.3+ is within the range of O.ltoreq.Fe.sup.3+ <2, x is a number represented by 1.ltoreq.x<20, z is a number represented by 0<z<3, and m is a number represented by 0.ltoreq.m<20, the product being formed by the thermal treatment of the compound of formula (I) at a temperature of about 100.degree. C. to about 200.degree. C. in an aqueous medium.
A hydrothermally treated product of a compound having a hydrotalcite-like crystal structure and represented by the following formula (I)
A composition for increasing at least one of hemoglobin and the serum iron level, said composition comprising
A method for increasing at least one of hemoglobin and the serum iron level, which comprises orally administering an amount, effective for increasing at least one of hemoglobin and the serum iron level, of a hydrothermally treated product of a compound having a hydrotalcite-like crystal structure and represented by the following formula (I)
Dependencies are inferred from the claim text.